SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001206774-11-001105
Filing Date
2011-05-03
Accepted
2011-05-03 07:30:45
Documents
10
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT regeneron_10q.htm 10-Q 931993
2 CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) exhibit31-1.htm EX-31.1 10026
3 CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) exhibit31-2.htm EX-31.2 10430
4 CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 exhibit32.htm EX-32 4464
  Complete submission text file 0001206774-11-001105.txt   2997028

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT regn-20110331.xml EX-101.INS 331322
6 XBRL TAXONOMY EXTENSION SCHEMA regn-20110331.xsd EX-101.SCH 13351
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE regn-20110331_pre.xml EX-101.PRE 106886
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE regn-20110331_lab.xml EX-101.LAB 186328
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE regn-20110331_cal.xml EX-101.CAL 44108
10 XBRL TAXONOMY EXTENSION DEFINITION DOCUMENT regn-20110331_def.xml EX-101.DEF 36220
Mailing Address
Business Address 777 OLD SAW MILL RIVER RD TARRYTOWN NY 10591-6707 9143477000
REGENERON PHARMACEUTICALS INC (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19034 | Film No.: 11802869
SIC: 2834 Pharmaceutical Preparations